...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: 3 Weeks To The 31st
Reply New Message
Back To Forum List View
Icon president 3 Weeks To The 31st
4
SanFrancisco99
Mar 10, 2017 10:17AM
Icon president Re: 3 Weeks To The 31st
5
BearDownAZ
Mar 10, 2017 11:22AM
Icon president Re: 3 Weeks To The 31st
4
SanFrancisco99
Mar 10, 2017 05:46PM

As of today, we are now 9 months since first dosing in the single agent ZEN-3694 trial and 3 months since they initiated the ZEN-3694/enzalutamide combo trial. The suspense is building......

3 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply